Relypsa, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (25)

View All

Latest Posts

About This Stock More About This Stock
Dow Jones Industrial Average Today Slumps After Weak Earnings, Lower Oil Prices
Article By: Garrett Baldwin
Thursday, July 21, 2016 9:22 PM EDT
The Dow Jones Industrial Average today snapped a nine-session winning streak, slumping after weaker earnings, falling oil prices, and a short-term end to the global sugar high of falling interest rates and more stimulus.
In this article: CMG, DAL, GM, IOC, JOY, LUV, P, T, UAL, V, XOM, KMTUY, INTC, SBUX, OIL, USO, AAL, RLYP
Read
4 Takeover Stocks To Buy This Summer
Article By: Bret Jensen
Sunday, June 5, 2016 10:39 AM EDT
Biotech has gone a real tear over the past three weeks after making several “false starts” over the past several months as it emerges from an immense bear market that began late in July of last year. This move feels more real than previous bounces.
In this article: ACAD, ARDX, BIIB, PTLA, RLYP Also: ANAC, XNPT, ABBV, CPXX, AGN, PFE, MDVN, MRK, SNY
Read
Mizuho Analyst Criticizes Valeant Pharmaceuticals Intl Inc And Relypsa Inc; Here’s Why
Article By: TipRanks
Tuesday, May 31, 2016 11:48 PM EDT
As Valeant Pharmaceuticals Intl Inc continues to face legal battles on several fronts and Relypsa Inc struggles to ramp sales of its new drug, Irina Rivkind Koffler of Mizuho explains why she remains bearish on both companies.
In this article: VRX, RLYP
Read
Relypsa Gains 8% On Competitor's FDA Rejection
Article By: Terry Chrisomalis
Friday, May 27, 2016 7:56 PM EDT
Although the day's news regarding the hyperkalemia drug was good for Relypsa, AZN escaped the day relatively unscathed due to good news for two of its other drugs.
In this article: RLYP, AZN
Read
Biotech's Week Ahead: Relypsa, GW Pharmaceuticals, Regeneron And Exelixis
Article By: TipRanks
Sunday, May 1, 2016 2:17 PM EDT
It’s an exciting week ahead for pharma companies Relypsa Inc, GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH), Regeneron Pharmaceuticals Inc and Exelixis, Inc., as analysts anticipate quarterly reports and sales updates on key drugs. Here is what to watch.
In this article: REGN, EXEL, GWPH, RLYP
Read
All Posts

Latest Tweets for $RLYP

No tweets yet!

PARTNER HEADLINES